
Senate resolution calls on FDA to reverse its policy on estriol
The U.S. Senate, following in the footsteps of the House, has introduced a resolution urging FDA to lift its restrictions on the use of estriol in bioidentical hormone preparation.
The U.S. Senate has now introduced a resolution calling on the Food & Drug Administration to reverse its policy barring estriol from being used in compounded bioidentical hormone replacement therapy. The resolution, S. Con. Res.88, was introduced by Senators John Cornyn (R, Texas) and Jim Bunning (R, Ky.) and follows a similar House resolution,
To see more Daily News articles,
To go to the Drug Topics homepage,
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.


























































































































































